Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
2seventy bio
Pharma
BMS buys cell therapy partner 2seventy bio for $286M
While the price for 2seventy marked a 88% premium to the biotech's previous close price, it still came below analysts' target valuation.
Angus Liu
Mar 11, 2025 10:12am
CDMO Resilience plots job cuts at former bluebird bio facility
Jan 8, 2025 2:47pm
BMS, 2seventy scrap Abecma trial in first-line multiple myeloma
Sep 25, 2024 10:52am
BMS' Abecma wins earlier myeloma nod with updated boxed warning
Apr 5, 2024 11:46am
FDA sets date for high-profile CAR-T advisory committee meeting
Feb 2, 2024 1:31pm
2seventy bio plots Abecma turnaround amid strategic pivot
Jan 30, 2024 11:25am
